| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CKJ/SFV070 |
| P8608 | Fatcat ID | release_r5dbvds4jbhgjiiucz3ohgixqm |
| P932 | PMC publication ID | 4581388 |
| P698 | PubMed publication ID | 26413289 |
| P5875 | ResearchGate publication ID | 282163286 |
| P50 | author | Markus Zeisbrich | Q86254818 |
| P2093 | author name string | Martin Zeier | |
| Vedat Schwenger | |||
| Lars P Kihm | |||
| Felix Drüschler | |||
| P2860 | cites work | Quantification of renal blood flow with contrast-enhanced ultrasound | Q30307073 |
| Contrast enhanced ultrasound of the kidneys: what is it capable of? | Q30444214 | ||
| The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography | Q30460279 | ||
| Standard B presentation vs. contrast-enhanced ultrasound (US-CE). A comparison of usefulness of different ultrasonographic techniques in the evaluation of the echo structure and size of haematomas inpost-renal transplant patients: A preliminary repo | Q30462705 | ||
| In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells | Q30466579 | ||
| Contrast-enhanced and targeted ultrasound | Q30477621 | ||
| The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. | Q34211494 | ||
| Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. | Q34388889 | ||
| Ultrasound contrast agents for hepatic imaging with nonlinear modes | Q35092523 | ||
| Ultrasound contrast imaging research | Q35217348 | ||
| Imaging of the renal transplant: comparison of MRI with duplex sonography | Q36382110 | ||
| The kidney: imaging with microbubble contrast agents. | Q36461467 | ||
| Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. | Q36871846 | ||
| Microbubble-enhanced US in body imaging: what role? | Q37790181 | ||
| Current and potential renal applications of contrast-enhanced ultrasound | Q37998704 | ||
| Ultrasonic microbubble contrast agents and the transplant kidney | Q39939505 | ||
| Thinking outside the "box"-the ultrasound contrast controversy | Q40141325 | ||
| Methods for measuring renal blood flow: total flow and regional distribution | Q40289471 | ||
| Methods of renal blood flow measurement | Q41137763 | ||
| Renal artery stenosis in kidney transplants | Q41681038 | ||
| Contrast-enhanced ultrasonography in the early period after kidney transplantation predicts long-term allograft function. | Q41701385 | ||
| Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. | Q42544482 | ||
| The renal arterial resistance index and renal allograft survival | Q43702596 | ||
| Diagnosis of acute cortical necrosis in renal transplantation by contrast-enhanced ultrasound: a preliminary experience | Q44560448 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Oral cyclosporine but not tacrolimus reduces renal transplant blood flow | Q44913861 | ||
| Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects | Q45723431 | ||
| Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus. | Q45923643 | ||
| Contrast-enhanced sonography in early kidney graft dysfunction. | Q46001924 | ||
| Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients | Q46534659 | ||
| Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy | Q46936599 | ||
| Ultrasound molecular imaging of transient acute myocardial ischemia with a clinically translatable P- and E-selectin targeted contrast agent: correlation with the expression of selectins. | Q51122012 | ||
| Technology overview: SonoVue (Bracco, Milan). | Q51542641 | ||
| Blood flow quantification with contrast-enhanced US: "entrance in the section" phenomenon--phantom and rabbit study. | Q52014466 | ||
| Arrival time parametric imaging: a new ultrasound technique for quantifying perfusion of kidney grafts. | Q52927327 | ||
| Detection of transplant renal artery stenosis in the early postoperative period with analysis of parenchymal perfusion with ultrasound contrast agent. | Q53104493 | ||
| Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. | Q53562870 | ||
| Intrarenal doppler flow analysis in patients with kidney transplantation and stable transplant function | Q54082650 | ||
| Perfusion disturbances of kidney graft parenchyma evaluated with contrast-enhanced ultrasonography in the immediate period following kidney transplantation. | Q54415926 | ||
| The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations | Q56997483 | ||
| Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation | Q57704487 | ||
| Contrast ultrasonography of the kidney: a new method for evaluation of renal perfusion in vivo | Q68922232 | ||
| Post-transplant renal artery stenosis: impact of therapy on long-term kidney function and blood pressure control | Q71050248 | ||
| Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging | Q73364109 | ||
| Real-Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power: First Experimental and Clinical Results Using Power Pulse Inversion Imaging | Q73434042 | ||
| Improved graft survival after renal transplantation in the United States, 1988 to 1996 | Q73502580 | ||
| [Detection of liver metastases--comparison of contrast--enhanced ultrasound using first versus second generation contrast agents] | Q73553434 | ||
| Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty | Q73933867 | ||
| The changing causes of graft loss and death after kidney transplantation | Q74493967 | ||
| Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversible | Q74755385 | ||
| Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? | Q77677742 | ||
| Surgically treated early complications after kidney transplantation | Q79124679 | ||
| Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients | Q79267330 | ||
| Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008 | Q80689480 | ||
| Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography | Q83794659 | ||
| Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species | Q84590342 | ||
| Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients | Q84595315 | ||
| Renal parenchyma perfusion spectrum and resistive index (RI) in ultrasound examinations with contrast medium in the early period after kidney transplantation | Q84784609 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 606-614 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) | Q26842221 |
| P1476 | title | When is contrast-enhanced sonography preferable over conventional ultrasound combined with Doppler imaging in renal transplantation? | |
| P478 | volume | 8 |
Search more.